Skip to content
10-Q

Quarterly Report

Nuvation Bio Inc. NUVB

0001193125-26-203964

← back to feed
Filed
May 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 348.2M sh
Shares Diluted Q1 2026 · Mar 31, 2026 377.52K sh
Shares Diluted Q1 2026 · Mar 31, 2025 338.61K sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 $5.07M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$42.63M
Long Term Debt Q1 2026 · Mar 31, 2026 $47.33M
Short Term Debt Q1 2026 · Mar 31, 2026 $5.79M
Short Term Debt Q1 2026 · Dec 31, 2025 $5.72M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $125.39M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $164.09M
Stockholders Equity Q1 2026 · Mar 31, 2026 $319.56M
Stockholders Equity Q1 2026 · Dec 31, 2025 $305.72M
Stockholders Equity Q1 2026 · Mar 31, 2025 $419.46M
Stockholders Equity Q1 2026 · Dec 31, 2024 $463.79M
Current Liabilities Q1 2026 · Mar 31, 2026 $79.52M
Current Liabilities Q1 2026 · Dec 31, 2025 $82.23M
Total Liabilities Q1 2026 · Mar 31, 2026 $290.68M
Total Liabilities Q1 2026 · Dec 31, 2025 $289.11M
Current Assets Q1 2026 · Mar 31, 2026 $591.53M
Current Assets Q1 2026 · Dec 31, 2025 $571.52M
Total Assets Q1 2026 · Mar 31, 2026 $610.24M
Total Assets Q1 2026 · Dec 31, 2025 $594.82M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.16
Eps Basic Q1 2026 · Mar 31, 2026 $0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.16
Sga Expense Q1 2026 · Mar 31, 2026 $38.31M
Sga Expense Q1 2026 · Mar 31, 2025 $35.39M
Rd Expense Q1 2026 · Mar 31, 2026 $35.05M
Rd Expense Q1 2026 · Mar 31, 2025 $24.6M
Net Income Q1 2026 · Mar 31, 2026 $5.4M
Net Income Q1 2026 · Mar 31, 2025 −$53.24M
Operating Income Q1 2026 · Mar 31, 2026 $3.88M
Operating Income Q1 2026 · Mar 31, 2025 −$59M
Revenue Q1 2026 · Mar 31, 2026 $83.23M
Revenue Q1 2026 · Mar 31, 2025 $3.08M